Brand Strategy

At Blue Latitude Health, Brand Strategy encompasses the development and delivery of customer-focused strategies and plans, which create long-term value to patients and brands.

This is where you’ll find our commentary, articles, and resources that relate to those strategies and plans, and the processes behind them.

surfer-perspective-4-executional-excellence

The Executional Excellence issue of Perspective magazine is live

Blue Latitude Health | 23rd May 2017

What drives us at BLH is the opportunity to make a real difference – and for our clients, that difference is measured both in customer outcomes and commercial outcomes. In the Executional Excellence edition of Perspective magazine, we explore topics around the ‘executional excellence’ theme – creating work that works. 

read more

Blue Latitude Health - branded image - Fields

From mountains of raw data to an engaging story: our experience as BHBIA Analyst Team of the Year finalists

Pany Koizi | 8th May 2017

Turning data into a meaningful and engaging story requires both creative and analytical thinking, and this is the exactly the approach we took in this year’s entry to the 'BHBIA Analyst Team of the Year' competition. Here, Pany Koizi outlines the multi-disciplinary approach used in our journey to the finals of the competition.

read more

channeling-your-inner-disruptor-kid-screaming-microphone

Channelling your inner disruptor

Jenna Earl | 5th April 2017

Channel strategy has long been a hot topic for pharma and is often regarded as the answer to many of today’s marketing challenges. Head of Brand Strategy Jenna Earl discusses these challenges faced by pharmaceutical marketers today, and if channel disruption is really the answer.

read more

Introducing_orello_Janssen

Using service design to improve patients’ quality of life

Eimear Power | 29th March 2017

Customer Experience Consultant Eimear Power talks through the process of developing Orello, a service for metastatic prostate cancer patients and their loved ones, in collaboration with Janssen.

read more

Influencer mapping

Influence mapping to improve the efficiency and effectiveness of your messaging

Pany Koizi | 1st March 2017

As companies work to find innovative marketing techniques to cut through the noise, influence mapping has seen an increase in popularity. Associate Consultant Pany Koizi talks through how to get the most out of the influence mapping process.

read more

photo-sad-man-powder-face

Are we harnessing the full emotional power of brand creativity?

Damien Parsonage | 30th September 2016

Creative Director Damien Parsonage breaks down the common misconception that pharma and healthcare marketing for healthcare professionals ought to be entirely scientific and rational. Brands are powerful; here's how to strengthen yours by infusing it with emotion.

read more

chessboard-strategy-photo

Marketing strategy in complex environments

Mark Assenti, Kulveer Singh | 19th September 2016

Age-old treatment protocols are being replaced with new and innovative treatment paradigms that will revolutionise the healthcare industry for years to come. Kulveer Singh and Mark Assenti talk through what this means for pharma strategists and their product lines.

read more

library-card-file-stock-photograph_DAM-vs-CMS-pharma-content-management

DAM and CMS: managing assets to maximise adoption and value

David Wood | 14th September 2016

Senior Account Executive Dave Wood talks us through what DAM and CMS are, the role they play in the future of healthcare marketing, and how they can be best utilised to maximise outcomes for pharma and agencies.

read more

products-as-portfolio_Blue-Latitude-Health_medicine-cabinet-treatment

Products as portfolios: positioning immuno-oncology products

Blue Latitude Health | 8th August 2016

The last few years have seen a huge proliferation in the number of products entering the oncology space, with a lot more currently being investigated in clinical trials. Effective positioning in this situation is vital to cut through the noise, so we've outlined some key learnings from our extensive experience in this area.

read more

Blue-Latitude-Health-branded-altitude-image

Biosimilars - the Brexit of the pharmaceutical industry?

Jenna Earl | 13th June 2016

In this article, Senior Consultant Jenna Earl explains what factors influence the uptake of biosimilars in the UK, comparing them to the same principles that help us navigate the complexities of Britain exiting the EU (Brexit).

read more